Back
Midland States Bancorp Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
1
MSBI
Midland States Bancorp
Last Price:
$17.35
Seasonality Move:
-2.5%
Sell
43
ALNY
Alnylam Pharmaceuticals
Last Price:
$268.29
Seasonality Move:
7.6%
Sell
1
Midland States Bancorp (MSBI)
is a Sell
Is Midland States Bancorp a Buy, Sell or Hold?
-
The current Midland States Bancorp [MSBI] share price is $17.30. The Score for MSBI is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
MSBI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MSBI Stock Price Chart
What is Midland States Bancorp's stock price today?
-
The Midland States Bancorp share price today is $17.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSBI is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $268.46The current trend is moderately bullish and ALNY is experiencing slight buying pressure.
MSBI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 27.73 | Sell |
Chaikin Money Flow: | -61196 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.86 - 19.16) | Sell |
Bollinger Bands (100): | (19.26 - 26.2) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.41 | Buy |
Relative Strength Index (14 RSI): | 55.64 | Buy |
Chaikin Money Flow: | 78938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.82 - 268.04) | Buy |
Bollinger Bands (100): | (240.65 - 270.25) | Buy |
MSBI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.79 | Sell |
20-day SMA: | 18.3 | Sell |
50-day SMA: | 19.74 | Sell |
200-day SMA: | 22.66 | Sell |
8-day EMA: | 17.76 | Sell |
20-day EMA: | 18.28 | Sell |
50-day EMA: | 19.72 | Sell |
200-day EMA: | 22.25 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 271.33 | Sell |
20-day SMA: | 255.41 | Buy |
50-day SMA: | 259.88 | Buy |
200-day SMA: | 253.94 | Buy |
8-day EMA: | 268.64 | Sell |
20-day EMA: | 261.32 | Buy |
50-day EMA: | 257.88 | Buy |
200-day EMA: | 244.57 | Buy |
Midland States Bancorp Earnings Growth & MSBI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.38 per share, and an increase next year of $0.21 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Midland States Bancorp Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |